Takuran is used in traditional Japanese, Korean, and Chinese medicine. It is produced from Lycopus lucidus TURCZ. (Lamiaceae), an herbaceous perennial that grows on lakesides and riversides of East Asia and North America. Previous studies on the constituents of L. lucidus have resulted in the isolation of caffeic acid derivatives, 1) flavonoids, 2,3) and terpenoids. 4) Takuran is used for the treatment of menstrual disorder, menstrual cramps, and cardiovascular diseases.
Recently, several biological activities of L. lucidus were reported such as anti-allergic effects, 6) cholesterol acyltransferase inhibitory activity, 4) and inhibitory effects on high glucose-induced vascular inflammation. 7) Hyaluronidase is an enzyme that degrades hyaluronic acid. Hyaluronidase inhibition is known to be related to various conditions and is expected to be useful for treating certain diseases, 8) including allergies. In previous studies, it was found that there are correlations between allergic reactions and hyaluronidase inhibitory activity. 9, 10) Rosmarinic acid, a phenylpropanoid, was reported to have various biological activities 11) including as a hyaluronidase inhibitor. 12) It is also known that many derivatives of rosmarinic acid; dimmers, trimers, and tetramers of caffeic acid; as well as oligomers of phenylpropanoids are found in Lamiaceae and other plants.
In this paper, 4 new phenylpropanoids and 18 known compounds were isolated from Takuran, and six phenylpropanoids were tested for their hyaluronidase inhibitory activities. Flakes of Takuran, produced from dried aerial parts of L. lucidus, were extracted with acetone-water (8 : 2). After the concentrated extract had been partitioned between water and diethyl ether, the water layer was fractionated by column chromatography (using a porous polymer gel column and reverse-phase columns) to afford four new phenylpropanoids (3, 5, 7, 9), six known phenylpropanoids (1, 2, 4, 6, 8, 10), and 12 known compounds. Rosmarinic acid (1) , clinopodic acid C (2), and clinopodic acid E (4) were isolated from Clinopodium chinense var. parviflorum in our previous study.
13 ) The structures of the other known compounds were identified by comparing their spectroscopic data with those in the literature as schizotenuin A (6), 14) 3-O-(caffeoyl)-rosmarinic acid (8) , 15) rosmarinic acid ethyl ester (10), 16) apigenin (11), 17) acacetin (12), 17) acacetin-7-O-b-D-glucuronopyranoside (13), 18) luteolin (14) , 17) scutellarin (15), 19) hispidulin (16), 20) 24) and (Ϫ)-syringaresinol (22 Hz, H-2ٞ) and 6.43 (1H, dd, Jϭ8.5, 2.0 Hz, H-6ٞ). These protons and their corresponding carbons showed the presence of a 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoic acid moiety. The H-8ٞ proton was correlated with the carbonyl carbon at d 166.8 (C-9Љ) in the heteronuclear multiple bond correlation (HMBC) spectrum (Fig. 2) . The absolute configurations of C-8Ј and C-8ٞ were determined to be R from the retention time of the amide derivative of 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoic acid, which was obtained by acidic hydrolysis of 3, in (S)-2-phenylglycine methyl ester.
13) The absolute stereochemistry of C-7Љ was found to be S from the circular dichroism (CD) spectrum, which showed a positive Cotton effect at 220-260 nm.
26) The coupling constant between H-7Љ and H-8Љ (Jϭ3.0 Hz) indicated a cis-orientation. 27, 28) These data suggested that the structure of 3 was as shown in Fig. 1 These protons and their corresponding carbons showed the presence of a 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoic acid moiety. The H-8ٞ proton was determined to be correlated with the carbonyl carbon at d 167.5 (C-9Љ) in the HMBC spectrum. The absolute stereochemistry of C-7Љ was indicated to be R from the CD spectrum, which showed a negative Cotton effect at 230-260 nm. 26) The absolute stereochemistry of C-7Љ and C-8Љ were both R as indicated by the finding that the coupling constant between H-7Љ and H-8Љ in the proton NMR spectrum (Jϭ5.0 Hz) was identical to that of clinopodic acid E. 13 ) Two 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoic acid moieties were determined to be R from the retention time of the amide derivative as in the case of 3.
13)
Lycopic acid C (7) showed a pseudomolecular ion peak at m/z 519.0927 (Calcd for C 27 H 19 O 11 , 519.0927) on the HR-FAB-MS spectrum. The 1 H-and 13 C-NMR spectra suggested the presence of three phenylpropanoid moieties. A similar compound, melitric acid B, was isolated from Melissa officinalis L. and had three phenylpropanoid moieties and the same molecular weight. 29) However, the indicated the presence of rosmarinic acid moiety. The C-8Ј configuration was established as R using the same method as used for 3 and 5. A singlet olefinic proton at d 6.98 (1H, H-7Љ) was found to be correlated with aromatic protons at d 7.61 (1H, d, Jϭ2.0 Hz, H-2Љ) and 7.19 (1H, dd, Jϭ8.5, 2.0 Hz, H-6Љ) in the NOE spectra. In the HMBC spectrum, the H-7Љ proton was indicated to be long range coupled with the carbons at d 125.8 (C-8Љ) and 157.7 (C-9Љ). Treatment of 7 with water for three days gave 3-O-(caffeoyl)rosmarinic acid (8) , 15) and treatment with MeOH for 3 d gave the compound 9. These hydrolysis and methyl esterification products suggested that 7 has a 8-substituted caffeic acid moiety bound to the 3,4-substituted rosmarinic acid moiety as shown in Fig. 1 . 13 C-NMR spectra of 9 were similar to those of 8 15) except for the presence of a methyl signal at d 3.70 (3H, s). In its HMBC spectrum, the methyl protons were found to be long range coupled with the C-9Љ carbon at d 164.3, and the aromatic proton at d 7.31 (1H, s, H-7Љ) was determined to be long range coupled with the C-8Љ carbon at d 138.5 and C-9Љ. These data showed that 9 was 3-O-(caffeoyl)rosmarinic acid-9Љ-methylester.
Although compounds 8 and 9 were isolated from the acetone extract of Takuran, 7 changed to 8 and 9 in water and MeOH under moderate conditions. So, they may have been artifacts.
Hyaluronidase inhibitory activity was measured for compounds 1-6 as shown in Table 1 . Rosmarinic acid was reported as a hyaluronidase inhibitor in Melissa officinalis L., 12) so it was regarded to be a positive control. Compounds 2-5 showed higher activity (IC 50 80.1, 134, 82.8, and 141 mM, respectively) than that of rosmarinic acid (1, IC 50 309 mM). Compound 6 was showed activity (IC 50 241 mM) comparable to that of rosmarinic acid. Aqueous extracts of L. lucidus inhibited mast cell-mediated immediate-type allergic reactions. 6) However, there is little available knowledge regarding the constituents of these extracts. Potent hyaluronidase inhibitors are assumed to suppress the degranulation of mast cells and possess anti-allergic activity. 9, 10, 12) Thus, the inhibitors (2-6) observed in this paper are expected to be anti-allergic components of L. lucidus and could be useful components for the care and prophylaxis of allergies and other diseases.
Experimental
General Procedure Optical rotations were recorded on a Jasco P-2300 polarimeter, and CD spectra were recorded on a Jasco J-700 spectropolarimeter.
1 H-NMR (400 MHz), 13 C-NMR (100 MHz), 1 H-1 H correlation spectroscopy (COSY), heteronuclear multiple quantum correlation (HMQC) (optimized for 1 J C-H ϭ145 Hz), and HMBC (optimized for n J C-H ϭ8 Hz) spectra were recorded on a Jeol JNM-AL400 FT-NMR spectrometer, and chemical shifts were given as d values with TMS as an internal standard. HR-FAB-MS data were obtained on a Jeol JMS700 mass spectrometer, using a m-nitrobenzyl alcohol or a glycerol matrix. A porous polymer gel (Mitsubishi Chemical, Diaion HP-20, 60ϫ300 mm) and an octadecyl silica (ODS) column (Cosmosil 140 C 18 -OPN, Nacalai Tesque, 150 g) were used for column chromatography. Preparative Yamazen Cartridge Column Chromatography (YCCC) was performed on a Jasco 2089 instrument (column, Ultra Pack ODS-SM-50C-M, Yamazen, 37ϫ100 mm; detector, UV at 210 nm). Preparative HPLC was performed on a Jasco 2089 instrument and detected by UV at 210 nm (columns, Inertsil ODS-3, GL Sciences, 30ϫ 500 mm; ODS-100V, Tosoh, 20ϫ250 mm; 5C 18 -AR-II, Cosmosil, 20ϫ250 mm; Capcell-Pak Ph, Shiseido, 20ϫ250 mm; YMC-Pack ODS-AM, YMC, 10ϫ300 mm; Mightysil RP-18 GP, Kanto Chemical, 10ϫ250 mm).
Plant Material Takuran, produced from dried Lycopus lucidus TURCZ., was purchased from Uchida Wakanyaku Co., Ltd. (Tokyo, Japan; the product number: 76Q3308). A voucher specimen is deposited at the herbarium of Tohoku Pharmaceutical University, No. 20080531. Extraction and Isolation Takuran, aerial plant parts (480 g) of L. lucidus, were extracted with acetone-water (8 : 2), (14 l) twice at 60°C for 6 h. The extract was then concentrated at reduced pressure, suspended in water (1.5 l), and extracted with ether (1.0 l) three times. The water layer (61.5 g) was dissolved in water and passed through a porous polymer gel column and eluted with water, 50% MeOH, and MeOH. The MeOH eluate (1.66 g) was separated using HPLC columns [Capcel pak Ph, mobile phase, acetonitrile-0.2% trifluoroacetic acid (TFA) in water (35 : 65); 5C 18 -AR-II, mobile phase, acetonitrile-0.2% TFA in water (35 : 65), (40 : 60)] to give compounds 2 (3.8 mg), 4 (7.2 mg), 7 (2.6 mg), 9 (1.6 mg), 11 (2.2 mg), 12 (2.6 mg), 14 (8.5 mg), 15 (1.9 mg), 17 (1.9 mg), 18 (2.8 mg), and 22 (5.9 mg). The 50% MeOH eluate (16.4 g) was chromatographed on a reversed-phase column using ODS and then eluted with 30%, 40%, 50%, 80% MeOH, and MeOH (fractions 1A-1E). Fraction 1B (1. (6) 241
Values represent the mean of 3 observations.
116.0 (C-5ٞ), 121.8 (C-6ٞ), 37.1 (C-7ٞ), 73.9 (C-8ٞ), 170.1 (C-9ٞ (S)-PGME and (R)-PGME Esters of 3-(3,4-Dihydroxyphenyl)-2-hydroxypropanoic Acid To 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoic acid (5 mg, each) obtained from rosmarinic acid 13) in N,N-dimethylformamide (DMF) (1.0 ml) was added (S)-phenylglycine methyl ester (PGME) or (R)-PGME (10 mg), and then benzotriazol-1-yl-oxy-tris-pyrrolidinophonium hexafluorophosphate (PyBOP) (15 mg), 1-hydroxybenzotriazole (HOBT) (5 mg), and N-methylmorpholine (20 ml) were added and the mixture was stirred for 10 h at room temperature. The reactions gave (S)-amide and (R)-amide.
13) The retention time of (S)-amide was 19.4 min and that of (R)-amide was 20.1 min. The analytical HPLC was performed on a Shiseido Capcell Pak C18 column (4.6ϫ250 mm) using acetonitrile-0.2% TFA in water (22.5 : 77.5) as the solvent (flow rate, 1 ml/min; detector, UV 210 nm).
Acidic Hydrolysis of Compounds 3, 5, 7, and 9 and Condensation with (S)-PGME Each compound (compounds 3 and 5: 2 mg; 7 and 9: 0.5 mg) was dissolved in 7% HCl (1 ml) and stirred for 2 h at 90°C. After concentration, the residues were dissolved in DMF and (S)-PGME (5 mg), PyBOP (7 mg), HOBT (3 mg), and N-methylmorpholine (15 ml) were added. The mixtures were then stirred for 10 h at room temperature to give (S)-amide; t R ϭ19.4 min in the HPLC analysis [column, Shiseido Capcell Pak C18 (4.6ϫ250 mm); solvent, acetonitrile-0.2% TFA in water (22.5 : 77.5); flow rate, 1 ml/min; detector, UV 210 nm].
Hyaluronidase Inhibitory Assay The inhibitory activity of hyaluronidase was determined by the Morgan-Elson method, which was modified by Davidson and Aronson. 10, [30] [31] [32] Samples dissolved in 0.1 M acetate buffer (0.2 ml) and hyaluronidase (Type IV-S: From Bovine Testes, 2140 units/mg solid, Sigma Chemical Co., St. Louis, U.S.A.) in buffer (final concentration: 4000 unit/ml, 0.1 ml) were mixed and the mixture was incubated at 37°C for 20 min. Then, compound 48/80 (Sigma Chemical Co., St. Louis, U.S.A.) in buffer (final concentration: 0.3 mg/ml, 0.2 ml) was added and incubated at 37°C for 20 min. After hyaluronic acid potassium salt (Sigma Chemical Co., St. Louis, U.S.A.) in buffer (final concentration: 0.4 mg/ml, 0.5 ml) had been added, the mixture was incubated at 37°C for 40 min. Then, the reaction was stopped by adding 0.4 M NaOH and bolate solution and then boiling the mixture in a water bath for 3 min. p-Dimethylaminobenzaldehyde (Wako Pure Chemical Industries Ltd., Osaka, Japan) acetate solution (6 ml) was then added and incubated at 37°C for 20 min. Acetate buffer was added in place of the sample as a control, and the buffer was added in place of hyaluronidase in buffer as a blank. The enzyme inhibitory activity (%) was calculated as follows: inhibitory activity (%)ϭ[(Control Abs 600 nm ϪControl blank Abs 600 nm )Ϫ(Sample Abs 600 nm ϪSam-ple blank Abs 600 nm )]/(Control Abs 600 nm ϪControl blank Abs 600 nm )ϫ100.
